AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT For Licensing Patent RightsExclusive License Agreement • August 15th, 2011 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
This amended and restated exclusive license agreement (the “Restated License Agreement”) is made and entered into on August 12, 2011 by and between THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate, having its principal office at 1800 Grant Street, 8th Floor, Denver, CO 80203 (hereinafter “University”) and ARCA biopharma, Inc., a Delaware corporation having its principal office at 8001 Arista Place, Suite 200, Broomfield, CO 80021 (hereinafter “Licensee”) (individually, “Party” and collectively the “Parties”).
